BridgeMD
Tests treatment safety and results for Histiocytosis
Official title Determination of Molecular Status, the Efficacy and Safety of Fluorodeoxyglucose in PET-CT Imaging
ClinicalTrials.gov ID: NCT04943211
What this study is testing
What is fluorodeoxyglucose (18F-FDG)?
fluorodeoxyglucose (18F-FDG) is an investigational medicine, being studied as a potential treatment for histiocytosis.
Also referred to as GLUNEKTIK; SYNEKTIK.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Prospective, low intervention, open, single-center, non-commercial clinical trial to improve diagnostics in patients with histiocytosis by assessing the molecular profile of the tumor tissues, monitoring its presence in free-circulating DNA, and determining the efficacy of fluorodeoxyglucose (18F-FDG) in PET-CT imaging.
- Phase 3: a large, late-stage study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 1 to 18
You may be able to join if
- Patient under 18 years of age at the time of inclusion.
- Histopathologically confirmed or suspected histiocytosis (based on prior test results).
- Signing of informed consent for trial participation according with current legal regulations.
You likely can't join if
- Lack of inclusion criteria.
- Pregnancy.
- Other acute or persistent disorders, behaviors or abnormal laboratory test results, which might increase the risk related to the participation in...
The study team makes the final eligibility decision.
Where it's taking place
- Warsaw, Mazovian, Poland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 1 year to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Warsaw, Mazovian, Poland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.